PM20D1 and Alzheimer disease: Furthermore, it has been demonstrated that PM20D1 is a methylation and expression QTL coupled to an AD-risk associated haplotype defined by rs708727 and rs960603, which displays enhancer-like characteristics and contacts the PM20D1 promoter via a haplotype-dependent, CCCTC-binding-factor-mediated chromatin loop [13].